CN1800372A - 组织工程化细胞外基质的制备方法 - Google Patents
组织工程化细胞外基质的制备方法 Download PDFInfo
- Publication number
- CN1800372A CN1800372A CNA2005100964633A CN200510096463A CN1800372A CN 1800372 A CN1800372 A CN 1800372A CN A2005100964633 A CNA2005100964633 A CN A2005100964633A CN 200510096463 A CN200510096463 A CN 200510096463A CN 1800372 A CN1800372 A CN 1800372A
- Authority
- CN
- China
- Prior art keywords
- cell
- preparation
- extracellular matrix
- nutrient solution
- stromatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002744 extracellular matrix Anatomy 0.000 title claims description 62
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 title claims description 58
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 title claims description 58
- 238000002360 preparation method Methods 0.000 title claims description 35
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 8
- 230000001954 sterilising effect Effects 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 36
- 235000015097 nutrients Nutrition 0.000 claims description 30
- 210000004027 cell Anatomy 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 15
- 230000008859 change Effects 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002609 medium Substances 0.000 claims description 12
- 230000003203 everyday effect Effects 0.000 claims description 11
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 244000309466 calf Species 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 210000000130 stem cell Anatomy 0.000 claims description 5
- 230000004069 differentiation Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 3
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 102000002070 Transferrins Human genes 0.000 claims description 3
- 108010015865 Transferrins Proteins 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 229940045110 chitosan Drugs 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 3
- 235000020774 essential nutrients Nutrition 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- 229960000890 hydrocortisone Drugs 0.000 claims description 3
- 150000002505 iron Chemical class 0.000 claims description 3
- 239000002953 phosphate buffered saline Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000010257 thawing Methods 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000005538 encapsulation Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 7
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000005022 packaging material Substances 0.000 abstract 1
- 238000011012 sanitization Methods 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 206010053615 Thermal burn Diseases 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000005012 migration Effects 0.000 description 4
- 238000013508 migration Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 208000028990 Skin injury Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000006424 Flood reaction Methods 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- -1 collegen filament Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108010023728 Alloderm Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000003995 blood forming stem cell Anatomy 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000003725 endotheliocyte Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940050561 matrix product Drugs 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000001665 muscle stem cell Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000001178 neural stem cell Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000003668 pericyte Anatomy 0.000 description 1
- 210000004261 periodontium Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 239000003351 stiffener Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
组别 | 例数 | 平均愈合时间(天) |
空白对照组 | 10 | 24.37±3.25 |
使用本发明细胞外基质组 | 10 | 13.65±3.41 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100964633A CN100400655C (zh) | 2005-12-02 | 2005-12-02 | 组织工程化细胞外基质的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100964633A CN100400655C (zh) | 2005-12-02 | 2005-12-02 | 组织工程化细胞外基质的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1800372A true CN1800372A (zh) | 2006-07-12 |
CN100400655C CN100400655C (zh) | 2008-07-09 |
Family
ID=36810585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100964633A Expired - Fee Related CN100400655C (zh) | 2005-12-02 | 2005-12-02 | 组织工程化细胞外基质的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100400655C (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101234215B (zh) * | 2008-03-06 | 2010-12-01 | 西安组织工程工程技术研究中心 | 无细胞复合型人工皮肤及其制备方法 |
CN102271634A (zh) * | 2008-11-04 | 2011-12-07 | 斯特拉塔特克公司 | 即用型经干燥和经辐照的皮肤等同物 |
CN105561398A (zh) * | 2015-10-13 | 2016-05-11 | 南开大学 | 一种组织工程多孔细胞外基质支架制备方法 |
CN106520673A (zh) * | 2016-12-24 | 2017-03-22 | 严志海 | 一种成纤维细胞培养基及其制备方法 |
CN106727246A (zh) * | 2017-02-08 | 2017-05-31 | 上海元茵生物科技有限公司 | 小牛血清细胞营养液 |
CN106860914A (zh) * | 2017-01-19 | 2017-06-20 | 浙江大学 | 一种经由细胞片层获得磷酸钙/细胞外基质薄膜的方法 |
CN108355172A (zh) * | 2018-04-17 | 2018-08-03 | 上海市第六人民医院 | 一种软组织修复用脱细胞罗非鱼皮仿生基质及其制备方法和应用 |
CN108355171A (zh) * | 2018-04-09 | 2018-08-03 | 青岛海洋生物医药研究院 | 脱细胞真皮基质引导组织再生膜材料及其制备方法和应用 |
CN108815094A (zh) * | 2018-07-05 | 2018-11-16 | 广州昕生医学材料有限公司 | 一种细胞外基质冻干粉的用途 |
CN109276757A (zh) * | 2018-08-31 | 2019-01-29 | 宁波大学 | 来源于体外培养的细胞外基质的制备方法及应用 |
CN114807005A (zh) * | 2022-04-09 | 2022-07-29 | 翌圣生物科技(上海)股份有限公司 | 使用动物尸体制备基质胶的方法 |
CN115105637A (zh) * | 2022-07-28 | 2022-09-27 | 上海交通大学医学院附属第九人民医院 | 结膜下成纤维细胞脱细胞基质在结膜重建方面的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1232233C (zh) * | 2003-09-02 | 2005-12-21 | 中国人民解放军第四军医大学口腔医学院 | 一种组织工程真皮的制备方法 |
CN1522766A (zh) * | 2003-09-05 | 2004-08-25 | 东南大学 | 脱细胞真皮基质的制备方法 |
-
2005
- 2005-12-02 CN CNB2005100964633A patent/CN100400655C/zh not_active Expired - Fee Related
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101234215B (zh) * | 2008-03-06 | 2010-12-01 | 西安组织工程工程技术研究中心 | 无细胞复合型人工皮肤及其制备方法 |
US9867904B2 (en) | 2008-11-04 | 2018-01-16 | Stratatech Corporation | Dried and irradiated skin equivalents for ready use |
CN102271634A (zh) * | 2008-11-04 | 2011-12-07 | 斯特拉塔特克公司 | 即用型经干燥和经辐照的皮肤等同物 |
US8580314B2 (en) | 2008-11-04 | 2013-11-12 | Stratatech Corporation | Dried and irradiated skin equivalents for ready use |
US8685463B2 (en) | 2008-11-04 | 2014-04-01 | Stratatech Corporation | Dried and irradiated skin equivalents for ready use |
CN102271634B (zh) * | 2008-11-04 | 2015-01-14 | 斯特拉塔特克公司 | 即用型经干燥和经辐照的皮肤等同物 |
US8992997B2 (en) | 2008-11-04 | 2015-03-31 | Stratatech Corporation | Dried and irradiated skin equivalents for ready use |
US9526811B2 (en) | 2008-11-04 | 2016-12-27 | Stratatech Corporation | Dried and irradiated skin equivalents for ready use |
CN105561398A (zh) * | 2015-10-13 | 2016-05-11 | 南开大学 | 一种组织工程多孔细胞外基质支架制备方法 |
CN105561398B (zh) * | 2015-10-13 | 2022-03-22 | 南开大学 | 一种组织工程多孔细胞外基质支架制备方法 |
CN106520673A (zh) * | 2016-12-24 | 2017-03-22 | 严志海 | 一种成纤维细胞培养基及其制备方法 |
CN106860914A (zh) * | 2017-01-19 | 2017-06-20 | 浙江大学 | 一种经由细胞片层获得磷酸钙/细胞外基质薄膜的方法 |
CN106727246A (zh) * | 2017-02-08 | 2017-05-31 | 上海元茵生物科技有限公司 | 小牛血清细胞营养液 |
CN108355171A (zh) * | 2018-04-09 | 2018-08-03 | 青岛海洋生物医药研究院 | 脱细胞真皮基质引导组织再生膜材料及其制备方法和应用 |
CN108355172A (zh) * | 2018-04-17 | 2018-08-03 | 上海市第六人民医院 | 一种软组织修复用脱细胞罗非鱼皮仿生基质及其制备方法和应用 |
CN108815094A (zh) * | 2018-07-05 | 2018-11-16 | 广州昕生医学材料有限公司 | 一种细胞外基质冻干粉的用途 |
CN109276757A (zh) * | 2018-08-31 | 2019-01-29 | 宁波大学 | 来源于体外培养的细胞外基质的制备方法及应用 |
CN114807005A (zh) * | 2022-04-09 | 2022-07-29 | 翌圣生物科技(上海)股份有限公司 | 使用动物尸体制备基质胶的方法 |
CN114807005B (zh) * | 2022-04-09 | 2023-11-21 | 翌圣生物科技(上海)股份有限公司 | 使用动物尸体制备基质胶的方法 |
CN115105637A (zh) * | 2022-07-28 | 2022-09-27 | 上海交通大学医学院附属第九人民医院 | 结膜下成纤维细胞脱细胞基质在结膜重建方面的应用 |
CN115105637B (zh) * | 2022-07-28 | 2023-11-10 | 上海交通大学医学院附属第九人民医院 | 结膜下成纤维细胞脱细胞基质在结膜重建方面的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100400655C (zh) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100400655C (zh) | 组织工程化细胞外基质的制备方法 | |
KR101056069B1 (ko) | 동물조직 분말을 이용한 다공성 3차원 지지체의 제조방법 | |
El Blidi et al. | Extraction methods, characterization and biomedical applications of collagen: A review | |
CN101757691B (zh) | 一种组织工程角膜的制备方法 | |
CN107224617B (zh) | 一种以脾脏细胞外基质为原料的水凝胶及其制备方法 | |
CN1735685A (zh) | 用未分化的间充质细胞治疗组织 | |
CN104055795B (zh) | 一种可注射植入剂及其制备方法 | |
CN110923193A (zh) | 皮肤溃疡修复基质用培养基的配制方法 | |
CN101773687A (zh) | 一种复合软组织补片的制备方法 | |
CN100368534C (zh) | 生物衍生羊膜、复合生物衍生羊膜及其制备方法 | |
CN1232233C (zh) | 一种组织工程真皮的制备方法 | |
CN101062429A (zh) | 一种组织工程化双层皮肤的构建方法与应用 | |
CN1836034A (zh) | 生产神经元的方法 | |
CN115429937A (zh) | 一种软组织填充修复材料及其制备方法 | |
CN107715181B (zh) | 一种可生物降解的组织工程皮肤支架的制备方法 | |
CN1259980C (zh) | 一种生物医用材料及其制备方法和用途 | |
AU2020267858A1 (en) | Novel polysaccharide-based hydrogel scaffolds for wound care | |
JPH1147258A (ja) | ゼラチンとコラーゲンとを含有する医用基材 | |
JP4959068B2 (ja) | 細胞組織再生用基材 | |
CN102172337B (zh) | 具有皮脂腺样结构的组织工程皮肤及其制备方法 | |
CN100462059C (zh) | 修复皮肤缺损的人工皮肤的制备方法 | |
CN100402097C (zh) | 琼脂/胶原皮肤创伤修复敷料及其制备方法和应用 | |
EP1504774A1 (en) | Artificial extracellular matrix and process for producing the same | |
CN109701089B (zh) | 一种可降解组织再生屏障膜及其制备方法 | |
CN114949358A (zh) | 一种用于深部创面修复的复合材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Yongjie Inventor after: Zhang Yonghe Inventor before: Wang Pingan |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170321 Address after: 523000 Guangdong City, Dongguan Songshan Lake high tech Industrial Development Zone, Taiwan high tech park, Taoyuan Road, No. 1, No. 1, Dong Guan biotechnology cooperation center, building 05, room 1 Patentee after: Dongguan Bo and Regenerative Medicine Co.,Ltd. Address before: 710075 Shaanxi high tech Zone in Xi'an City, Feng Hui Nan Lu new city garden 2 maple Jiezuo unit 902 Patentee before: Wang Pingan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170718 Address after: 710048, Shaanxi District, Xi'an province Baqiao Textile Industrial Park standard factory building, B6 building, 3-4 floor Patentee after: XI'AN BOHE MEDICAL TECHNOLOGY Co.,Ltd. Address before: 523000 Guangdong City, Dongguan Songshan Lake high tech Industrial Development Zone, Taiwan high tech park, Taoyuan Road, No. 1, No. 1, Dong Guan biotechnology cooperation center, building 05, room 1 Patentee before: Dongguan Bo and Regenerative Medicine Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180103 Address after: 523000 Guangdong City, Dongguan Songshan Lake high tech Industrial Development Zone, Taiwan high tech park, Taoyuan Road, No. 1, No. 1, Dong Guan biotechnology cooperation center, building 05, room 1 Patentee after: Dongguan Bo and Regenerative Medicine Co.,Ltd. Address before: 710048, Shaanxi District, Xi'an province Baqiao Textile Industrial Park standard factory building, B6 building, 3-4 floor Patentee before: XI'AN BOHE MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 523808 Dongguan, Guangdong, Songshan Lake high tech Industrial Development Zone, Taiwan high tech park, Taoyuan Road, 1, No. 1, 1, 05, room biotechnology cooperation center. Patentee after: GUANGDONG BO YU REGENERATIVE MEDICINE CO.,LTD. Address before: 523000 Dongguan, Guangdong, Songshan Lake high tech Industrial Development Zone, Taiwan high tech park, Taoyuan Road, 1, No. 1, 1, 05, room biotechnology cooperation center. Patentee before: Dongguan Bo and Regenerative Medicine Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080709 |